title: Clinical potential of GM-CSF in HIV-infected patients: Studies at the Memorial Sloan Kettering Cancer Center.
authors.affiliation: Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
authors.forename: S E
authors.initials: SE
authors.lastname: Krown
authors.forename: J
authors.initials: J
authors.lastname: Paredes
authors.forename: J W
authors.initials: JW
authors.lastname: Gold
authors.forename: D
authors.initials: D
authors.lastname: Bundow
authors.forename: W
authors.initials: W
authors.lastname: Anselmo
authors.forename: K
authors.initials: K
authors.lastname: O'Boyle
authors.forename: N
authors.initials: N
authors.lastname: Flomenberg
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications / Q000628:therapy*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D009503:Neutropenia / Q000139:chemically induced / Q000517:prevention & control*; D011994:Recombinant Proteins; D012514:Sarcoma, Kaposi / Q000150:complications / Q000628:therapy; D015215:Zidovudine / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D015215:Zidovudine; D016178:Granulocyte-Macrophage Colony-Stimulating Factor